Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DARATUMUMAB Cause Clostridium difficile colitis? 58 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 58 reports of Clostridium difficile colitis have been filed in association with DARATUMUMAB (DARZALEX). This represents 0.2% of all adverse event reports for DARATUMUMAB.

58
Reports of Clostridium difficile colitis with DARATUMUMAB
0.2%
of all DARATUMUMAB reports
18
Deaths
39
Hospitalizations

How Dangerous Is Clostridium difficile colitis From DARATUMUMAB?

Of the 58 reports, 18 (31.0%) resulted in death, 39 (67.2%) required hospitalization, and 10 (17.2%) were considered life-threatening.

Is Clostridium difficile colitis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DARATUMUMAB. However, 58 reports have been filed with the FAERS database.

What Other Side Effects Does DARATUMUMAB Cause?

Plasma cell myeloma (2,980) Infusion related reaction (2,557) Off label use (2,494) Pneumonia (1,450) Neutropenia (1,351) Drug ineffective (1,110) Thrombocytopenia (1,089) Death (1,088) Pyrexia (1,032) Dyspnoea (996)

What Other Drugs Cause Clostridium difficile colitis?

CYCLOPHOSPHAMIDE (717) PREDNISONE (619) DEXAMETHASONE (575) METHOTREXATE (562) ETOPOSIDE (503) CYTARABINE (489) VINCRISTINE (482) LENALIDOMIDE (388) METHYLPREDNISOLONE (385) CIPROFLOXACIN (378)

Which DARATUMUMAB Alternatives Have Lower Clostridium difficile colitis Risk?

DARATUMUMAB vs DARATUMUMAB\HYALURONIDASE-FIHJ DARATUMUMAB vs DARBEPOETIN ALFA DARATUMUMAB vs DARIDOREXANT DARATUMUMAB vs DARIFENACIN HYDROBROMIDE DARATUMUMAB vs DAROLUTAMIDE

Related Pages

DARATUMUMAB Full Profile All Clostridium difficile colitis Reports All Drugs Causing Clostridium difficile colitis DARATUMUMAB Demographics